To Protect Seniors, Modernize Regulations by Passing LTC Pharmacy Definition
Morning Consult | February 28, 2020 By Alan G. Rosenbloom When it comes to the “alphabet soup” of three- and four-letter federal agencies, one’s eyes can glaze over in confusion about what they do, why they do it and how average citizens benefit from their federally funded oversight. In the realm of health policy and our read more…
To boost transparency, amend bills to require PBM disclosure data related to seniors residing in long-term care facilities
McKnight’s Long–Term Care News – February 10, 2020 By Alan G. Rosenbloom To better ensure consumers and the Centers for Medicare & Medicaid Services (CMS) have access to drug pricing information relevant to seniors residing in long term care facilities, we believe the Senate Finance Committee-introduced Prescription Drug Pricing Reduction Act (PDPRA) and the Lower read more…
New advocacy tool offers lawmaker education about long-term care pharmacy clinical value, benefits
McKnight’s Long-Term Care News– January 13, 2020 By Fred Burke As every practitioner and advocate within our broader long-term care space knows, it’s becoming increasingly difficult to break through the noise when it comes to engaging with and educating policymakers about the intrinsic value the long-term care community provides. Given the health challenges America faces, read more…
To Help Patients, Reform The Drug Pricing System Don’t Impose Price Controls
Forbes- December 13, 2019 By: Wayne Winegarden Yesterday the House passed the ill-considered “Pelosi bill” that would impose draconian price controls on drugs. Ignoring the bill’s many adverse impacts, price control advocates like Speaker Pelosi appear to believe that these command and control schemes can solve the systemic health care affordability problem. But, as the read more…
Why Millions of Senior Citizens Can’t Get the Drugs They Need
Bloomberg Government By John Tozzi – September 19, 2019 Senior citizens who try to fill prescriptions have them rejected at the pharmacy counter millions of times each year because their doctors either don’t, or are unable to, check whether a patient’s Medicare plan covers a particular drug. That’s the upshot of a new report from a federal watchdog that read more…
As CMS Mitigates Medicaid ‘Spread Pricing’ Abuse, Time to Address Medicare Abuses
Under the leadership of Centers for Medicare and Medicaid Services Administrator Seema Verma, the Trump administration recently released key guidance mitigating pharmacy benefit managers’ abusive “spread pricing” practices in state Medicaid-managed care programs…Read More.
Protect LTC from unintended consequences of drug pricing reform
McKnight’s LTC News
As Congress and the Trump Administration advance sweeping prescription drug price reforms, it is essential to recognize independent long-term care pharmacies…Read More.
Unchecked Health Care Mergers Threaten Seniors’ Access to Prescription Drugs
Pharmacy benefit managers are the latest industry group set to appear before the Senate Finance Committee to detail their role in the drug pricing supply chain and offer ideas to lower prescription drug prices…Read More.
Comment Letter: CMS Proposed Rule: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses
RE: CMS Proposed Rule: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses, CMS 4180-P, RIN 0938-AT92, 83 Fed. Reg. 62152…Read More.